1. Home
  2. Stocks
  3. Kims Share Price

Krishna Institute of Medical Sciences Share Price

Healthcare Large Cap

₹556.80 +8.75 (1.6%)

05 Nov, 2024 22:05

SIP TrendupStart SIP in KIMS

Start SIP
Performance Financial Technical Events FnO Shareholding Pattern More FAQ’s

Performance

  • Low
  • ₹541
  • High
  • ₹559
  • 52 Week Low
  • ₹350
  • 52 Week High
  • ₹580
  • Open Price₹554
  • Previous Close₹548
  • Volume159,644

Investment Returns

  • Over 1 Month + 1.28%
  • Over 3 Month + 30.96%
  • Over 6 Month + 39.76%
  • Over 1 Year + 49.66%
SIP Lightning

Smart Investing Starts Here Start SIP with Krishna Institute of Medical Sciences for Steady Growth!

Krishna Institute of Medical Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 70.5
  • PEG Ratio
  • -7.8
  • Market Cap Cr
  • 22,280
  • P/B Ratio
  • 10.6
  • Average True Range
  • 19.36
  • EPS
  • 5.8
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.02
  • RSI
  • 59.62
  • MFI
  • 53.32

Krishna Institute of Medical Sciences Financial

IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations327.40304.85302.06316.25298.90
Total Income From Operations327.40304.85302.06316.25298.90
P/L Before Interest, Excpt. Items & Tax85.4069.7878.9289.0784.06
P/L Before Exceptional Items & Tax81.6067.4777.7189.0283.98
P/L After Tax from Ordinary Activities60.7048.1958.3666.1662.63
Net Profit/Loss For the Period60.7048.1958.3666.1662.63
IndicatorMar 24Mar 23
Revenue From Operations [Gross]1,197.561,105.98
Revenue From Operations [Net]1,197.561,105.98
Total Operating Revenues1,222.051,132.02
Total Revenue1,237.591,155.52
Total Expenses919.42818.19
Profit/Loss Before Tax318.17337.33
Profit/Loss For The Period235.34252.49
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity262.39269.96
Net Cash Used In Investing Activity-568.65-236.58
Net Cash Used in Finance Activity288.64-15.14
Net Inc/Dec In Cash And Equivalent-17.6218.24
Cash And Equivalent End Of Year20.4838.10
IndicatorMar 24Mar 23
Total Share Capital80.0380.03
Total Non-Current Liabilities320.7961.53
Total Current Liabilities209.26119.68
Total Capital And Liabilities2,396.511,812.07
Total Non-Current Assets2,095.341,575.02
Total Current Assets301.17237.04
Total Assets2,396.511,812.07
Indicator20242023
EBIT Margin (%)26.3329.90
Return On Capital Employed (%)14.7120.00
Return On Equity (%)12.6015.48
Long Term Debt To Equity (%)13.770.00
Book Value/Share (INR)46.6440.76
IndicatorJun 24Mar 24Dec 23Sep 23Jun 23
Net Sales/Income from operations688.40633.80605.84652.48606.03
Total Income From Operations688.40633.80605.84652.48606.03
P/L Before Interest, Excpt. Items & Tax145.00116.48115.00147.55127.91
P/L Before Exceptional Items & Tax127.10100.12102.57138.64118.58
P/L After Tax from Ordinary Activities95.2071.6276.67101.2986.67
Net Profit/Loss For the Period95.2071.6276.67101.2986.67
IndicatorMar 24Mar 23
Revenue From Operations [Gross]2,474.002,167.66
Revenue From Operations [Net]2,474.002,167.66
Total Operating Revenues2,498.142,197.68
Total Revenue2,511.202,223.55
Total Expenses2,051.291,753.47
Profit/Loss Before Tax459.91484.91
Profit/Loss For The Period336.28365.81
IndicatorMar 24Mar 23
Net CashFlow - Operating Activity521.09432.09
Net Cash Used In Investing Activity-752.56-615.60
Net Cash Used in Finance Activity216.7688.34
Net Inc/Dec In Cash And Equivalent-14.7235.98
Cash And Equivalent End Of Year46.8961.61
IndicatorMar 24Mar 23
Total Share Capital80.0380.03
Total Non-Current Liabilities1,306.50706.87
Total Current Liabilities452.29296.47
Total Capital And Liabilities3,852.022,941.30
Total Non-Current Assets3,304.582,463.67
Total Current Assets547.44477.64
Total Assets3,852.022,941.30
Indicator20242023
EBIT Margin (%)20.2922.77
Return On Capital Employed (%)14.9118.92
Return On Equity (%)16.9620.14
Long Term Debt To Equity (%)50.7329.79
Book Value/Share (INR)52.3148.43

Krishna Institute of Medical Sciences Technicals

EMA & SMA

Current Price
₹556.80
+ 8.75 (1.6%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹539.29
  • 50 Day
  • ₹525.69
  • 100 Day
  • ₹496.21
  • 200 Day
  • ₹458.73

Resistance and Support

552.12 Pivot Speed
  • R3 582.13
  • R2 570.57
  • R1 563.68
  • S1 545.23
  • S2 533.67
  • S3 526.78

Is Krishna Institute of Medical Sciences Worth Buying?

BUY SELL HOLD

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Krishna Institute of Medical Sciences Ltd. (KIMS) is a leading healthcare provider in India, operating a network of multi-specialty hospitals. It offers high-quality medical care across various specialties, serving patients in both urban and rural regions. Krishna Institute Of Medical Sciences has an operating revenue of Rs. 2,580.51 Cr. on a trailing 12-month basis. An annual revenue growth of 13% is good, Pre-tax margin of 18% is great, ROE of 16% is good. The company has a debt to equity of 51%, which is bit higher. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 22% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 3% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 68 which is a FAIR score but needs to improve its earnings, a RS Rating of 74 which is FAIR indicating the recent price performance, Buyer Demand at A which is evident from recent demand for the stock, Group Rank of 50 indicates it belongs to a fair industry group of Medical-Hospitals and a Master Score of B is close to being the best. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock definitely has some strength, you may want to examine it in more detail. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation. (+)

Krishna Institute of Medical Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-09 Quarterly Results
2024-08-07 Quarterly Results
2024-06-28 Stock Split
2024-05-16 Audited Results
2024-02-03 Quarterly Results
Date Purpose Remarks
2024-09-13 Split Rs.0.00 split from Rs. 10/- to Rs. 2/-.

Krishna Institute of Medical Sciences F&O

Krishna Institute of Medical Sciences Shareholding Pattern

38.82%
25.3%
5.59%
17.84%
0.01%
10.61%
1.83%
  • NSE Symbol
  • KIMS
  • BSE Symbol
  • 543308
  • Chairman & Managing Director
  • Dr. Bhaskara Rao Bollineni
  • ISIN
  • INE967H01025

Krishna Institute of Medical Sciences FAQs

Krishna Institute of Medical Sciences share price is ₹556 As on 05 November, 2024 | 21:51

The Market Cap of Krishna Institute of Medical Sciences is ₹22279.7 Cr As on 05 November, 2024 | 21:51

The P/E ratio of Krishna Institute of Medical Sciences is 70.5 As on 05 November, 2024 | 21:51

The PB ratio of Krishna Institute of Medical Sciences is 10.6 As on 05 November, 2024 | 21:51

Q2FY23
Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

The Vigilance Awareness Week for the year 2024 (VAW 2024) would be observed from October 28, 2024 to November 03, 2024
“सत्यनिष्ठा की संस्कृनि सेराष्र की समद्ृधि” “Culture of Integrity for Nation's Prosperity”
e-pledge link (https://pledge.cvc.nic.in/)

5paisa Capital Ltd. CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI-registered Mutual Fund Distributor | AMFI REGN No.: ARN-104096 | Date of initial Registration: 30/07/2015 | Current validity of ARN : 30/07/2027 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

*Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of ₹10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

Contact Us

Attention Investors

  • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
  • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
  • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

Email: support@5paisa.com

Support Desk Helpline: 8976689766

©2024, 5paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.